Catalyst Wire Dossier Catalyst Wire Dossier

BIDIL

Hydralazine hydrochloride and isosorbide dinitrate · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for BIDIL, covering 2013-03-27 to 2021-01-13. Get the full timeline:

Most recent: FDA Approved: BIDIL — Supplemental Application (Azurity Pharmaceuticals, Inc.)

See pricing